Clinical Trials Directory

Trials / Completed

CompletedNCT02446483

A Bioequivalence Study of Idiazole 20mg DR Tabs and PARIET® 20 mg DR Tabs After a Single Oral Dose Administration Under Fasting Conditions in Healthy Adults

Comparative Randomized, Single Dose, Two-way Crossover Open-label Study to Determine the Bioequivalence of Rabeprazole From Idiazole 20mg DR Tabs (GSK, Egypt)and PARIET 20 mg DR Tabs (JANSSEN, EGYPT) After a Single Oral Dose Administration of Each to Healthy Adults Under Fasting Conditions

Status
Completed
Phase
Phase 4
Study type
Interventional
Enrollment
60 (actual)
Sponsor
GlaxoSmithKline · Industry
Sex
All
Age
18 Years – 55 Years
Healthy volunteers
Accepted

Summary

This is an open-label, randomized, single dose, two-sequence, two-period crossover study, separated by 7 days washout interval from the first study drug administration. In this study, the bioavailability of Rabeprazole from Idiazole 20 milligram (mg) delayed release (DR) tablets and PARIET 20 mg DR tablets after a single oral dose administration of each to healthy adults under fasting conditions, will be investigated by determining the 90% confidence limits for the log-transformed ratio (Test product / Reference product) for the bioequivalence parameters. The influence of sequence, product and period effect will be tested by analysis of variance (ANOVA). In this study a total of 60 subjects plus 1-4 additional subjects will be enrolled and split into two groups (Group A and B) of 30 each. For each subject, a total of 33 blood draws will be done and the volume of blood will not exceed 300 milliliters (mL) for the study. PARIET is a registered trademark of EISAI Co. Limited.

Conditions

Interventions

TypeNameDescription
DRUGIdiazole 20mg DR tabsDelayed release tablets containing 20 mg of rabeprazole
DRUGPARIET 20 mg DR tabsOrally administered, delayed-release, enteric-coated tablets containing 20 mg of rabeprazole sodium.

Timeline

Start date
2014-03-19
Primary completion
2014-03-26
Completion
2014-03-26
First posted
2015-05-18
Last updated
2017-11-17
Results posted
2017-06-14

Locations

1 site across 1 country: Egypt

Source: ClinicalTrials.gov record NCT02446483. Inclusion in this directory is not an endorsement.